Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial.
Saved in:
| Title: | Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial. |
|---|---|
| Authors: | Vera P; Nuclear Medicine Department and QuantIF LITIS (EA4108), Centre Henri Becquerel, Rouen, France. Electronic address: pierre.vera@chb.unicancer.fr., Thureau S; Radiotherapy Department and QuantIF LITIS (EA4108), Centre Henri Becquerel, Rouen, France., Le Tinier F; Radiotherapy Department, Centre Oscar Lambret, Lille, France., Chaumet-Riffaud P; Clinical Research Department, Hôpital National des 15-20, Paris, France., Hapdey S; Nuclear Medicine Department and QuantIF LITIS (EA4108), Centre Henri Becquerel, Rouen, France., Kolesnikov-Gauthier H; Nuclear Medicine Department, Centre Oscar Lambret, Lille, France., Martin E; Radiotherapy Department, Centre Georges-François Leclerc, Dijon, France., Berriolo-Riedinger A; Nuclear Medicine, Centre Georges-François Leclerc, Dijon, France., Pourel N; Unité Fonctionnelle Onco-Thoracique, Institut du Cancer, Avignon, France., Broglia JM; Nuclear Medicine Deparment, Institut Sainte-Catherine, Avignon, France., Boissellier P; Radiotherapy Department, Institut du Cancer de Montpellier, Montpellier, France., Guillemard S; Nuclear Medicine Department, Institut du Cancer de Montpellier, Montpellier, France., Salem N; Radiotherapy Department, Institut Paoli-Calmettes, Marseille, France., Brenot-Rossi I; Nuclear Medicine Department, Institut Paoli-Calmettes, Marseille, France., Le Péchoux C; Radiation Oncology Department, Gustave Roussy, Villejuif, France., Berthold C; Radiation Oncology Department, Gustave Roussy, Villejuif, France., Giroux-Leprieur E; University Paris-Saclay, Department of Respiratory Diseases and Thoracic Oncology, Assistance Publique-Hôpitaux de Paris, Ambroise Paré Hospital, Boulogne-Billancourt, France., Moreau D; Oncology Radiotherapy Department, Paris Cité University, European Hospital Georges-Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France., Guillerm S; Department of Radiation Therapy, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France., Benali K; Nuclear Medicine Department, Hôpital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris Nord, Paris, France., Tessonnier L; Nuclear Medicine Department, Centre Intercommunal Sainte-Musse de Toulon-La Seyne-sur-mer, Toulon, France., Audigier-Valette C; Pneumology Department, Centre Intercommunal Sainte-Musse de Toulon-La Seyne-sur-mer, Toulon, France., Lerouge D; Radiotherapy Department, Centre Francois Baclesse, Caen, France., Quak E; Nuclear Medicine Department, Centre Francois Baclesse, Caen, France., Massabeau C; Radiotherapy Department, Institut Claudius Regaud - Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Courbon F; Nuclear Medicine Department, Institut Claudius Regaud - Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Moisson P; Radiotherapy Department, Hopital René Huguenin - Institut Curie, Saint-Cloud, France., Larrouy A; Radiotherapy Department, Centre de Cancerologie Paris Nord, Sarcelles, France., Modzelewski R; Nuclear Medicine Department and QuantIF LITIS (EA4108), Centre Henri Becquerel, Rouen, France., Gouel P; Nuclear Medicine Department and QuantIF LITIS (EA4108), Centre Henri Becquerel, Rouen, France., Ghazzar N; Nuclear Medicine Department, Paris Cité University, European Hospital Georges-Pompidou - Assistance Publique-Hôpitaux de Paris Centre, Paris, France., Langlais A; Clinical Research Unit, Intergroupe Francophone de Cancérologie Thoracique, Paris, France., Amour E; Clinical Research Unit, Intergroupe Francophone de Cancérologie Thoracique, Paris, France., Zalcman G; Université Paris Cité, Thoracic Oncology Department, Centre d'Investigation Clinique Institut National de la Santé et de la Recherche Médicale 1425, Hôpital Bichat-Claude Bernard, Institut du Cancer - Assistance Publique-Hôpitaux de Paris Nord, Paris, France., Giraud P; Oncology Radiotherapy Department, Paris Cité University, European Hospital Georges-Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France. |
| Source: | The Lancet. Oncology [Lancet Oncol] 2024 Sep; Vol. 25 (9), pp. 1176-1187. Date of Electronic Publication: 2024 Aug 09. |
| Publication Type: | Journal Article; Multicenter Study; Clinical Trial, Phase II; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39134086 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [<superscript>18</superscript>F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Vera+P%22">Vera P</searchLink>; Nuclear Medicine Department and QuantIF LITIS (EA4108), Centre Henri Becquerel, Rouen, France. Electronic address: pierre.vera@chb.unicancer.fr.<br /><searchLink fieldCode="AU" term="%22Thureau+S%22">Thureau S</searchLink>; Radiotherapy Department and QuantIF LITIS (EA4108), Centre Henri Becquerel, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Le+Tinier+F%22">Le Tinier F</searchLink>; Radiotherapy Department, Centre Oscar Lambret, Lille, France.<br /><searchLink fieldCode="AU" term="%22Chaumet-Riffaud+P%22">Chaumet-Riffaud P</searchLink>; Clinical Research Department, Hôpital National des 15-20, Paris, France.<br /><searchLink fieldCode="AU" term="%22Hapdey+S%22">Hapdey S</searchLink>; Nuclear Medicine Department and QuantIF LITIS (EA4108), Centre Henri Becquerel, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Kolesnikov-Gauthier+H%22">Kolesnikov-Gauthier H</searchLink>; Nuclear Medicine Department, Centre Oscar Lambret, Lille, France.<br /><searchLink fieldCode="AU" term="%22Martin+E%22">Martin E</searchLink>; Radiotherapy Department, Centre Georges-François Leclerc, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Berriolo-Riedinger+A%22">Berriolo-Riedinger A</searchLink>; Nuclear Medicine, Centre Georges-François Leclerc, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Pourel+N%22">Pourel N</searchLink>; Unité Fonctionnelle Onco-Thoracique, Institut du Cancer, Avignon, France.<br /><searchLink fieldCode="AU" term="%22Broglia+JM%22">Broglia JM</searchLink>; Nuclear Medicine Deparment, Institut Sainte-Catherine, Avignon, France.<br /><searchLink fieldCode="AU" term="%22Boissellier+P%22">Boissellier P</searchLink>; Radiotherapy Department, Institut du Cancer de Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Guillemard+S%22">Guillemard S</searchLink>; Nuclear Medicine Department, Institut du Cancer de Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Salem+N%22">Salem N</searchLink>; Radiotherapy Department, Institut Paoli-Calmettes, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Brenot-Rossi+I%22">Brenot-Rossi I</searchLink>; Nuclear Medicine Department, Institut Paoli-Calmettes, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Le+Péchoux+C%22">Le Péchoux C</searchLink>; Radiation Oncology Department, Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Berthold+C%22">Berthold C</searchLink>; Radiation Oncology Department, Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Giroux-Leprieur+E%22">Giroux-Leprieur E</searchLink>; University Paris-Saclay, Department of Respiratory Diseases and Thoracic Oncology, Assistance Publique-Hôpitaux de Paris, Ambroise Paré Hospital, Boulogne-Billancourt, France.<br /><searchLink fieldCode="AU" term="%22Moreau+D%22">Moreau D</searchLink>; Oncology Radiotherapy Department, Paris Cité University, European Hospital Georges-Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Guillerm+S%22">Guillerm S</searchLink>; Department of Radiation Therapy, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Benali+K%22">Benali K</searchLink>; Nuclear Medicine Department, Hôpital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris Nord, Paris, France.<br /><searchLink fieldCode="AU" term="%22Tessonnier+L%22">Tessonnier L</searchLink>; Nuclear Medicine Department, Centre Intercommunal Sainte-Musse de Toulon-La Seyne-sur-mer, Toulon, France.<br /><searchLink fieldCode="AU" term="%22Audigier-Valette+C%22">Audigier-Valette C</searchLink>; Pneumology Department, Centre Intercommunal Sainte-Musse de Toulon-La Seyne-sur-mer, Toulon, France.<br /><searchLink fieldCode="AU" term="%22Lerouge+D%22">Lerouge D</searchLink>; Radiotherapy Department, Centre Francois Baclesse, Caen, France.<br /><searchLink fieldCode="AU" term="%22Quak+E%22">Quak E</searchLink>; Nuclear Medicine Department, Centre Francois Baclesse, Caen, France.<br /><searchLink fieldCode="AU" term="%22Massabeau+C%22">Massabeau C</searchLink>; Radiotherapy Department, Institut Claudius Regaud - Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Courbon+F%22">Courbon F</searchLink>; Nuclear Medicine Department, Institut Claudius Regaud - Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Moisson+P%22">Moisson P</searchLink>; Radiotherapy Department, Hopital René Huguenin - Institut Curie, Saint-Cloud, France.<br /><searchLink fieldCode="AU" term="%22Larrouy+A%22">Larrouy A</searchLink>; Radiotherapy Department, Centre de Cancerologie Paris Nord, Sarcelles, France.<br /><searchLink fieldCode="AU" term="%22Modzelewski+R%22">Modzelewski R</searchLink>; Nuclear Medicine Department and QuantIF LITIS (EA4108), Centre Henri Becquerel, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Gouel+P%22">Gouel P</searchLink>; Nuclear Medicine Department and QuantIF LITIS (EA4108), Centre Henri Becquerel, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Ghazzar+N%22">Ghazzar N</searchLink>; Nuclear Medicine Department, Paris Cité University, European Hospital Georges-Pompidou - Assistance Publique-Hôpitaux de Paris Centre, Paris, France.<br /><searchLink fieldCode="AU" term="%22Langlais+A%22">Langlais A</searchLink>; Clinical Research Unit, Intergroupe Francophone de Cancérologie Thoracique, Paris, France.<br /><searchLink fieldCode="AU" term="%22Amour+E%22">Amour E</searchLink>; Clinical Research Unit, Intergroupe Francophone de Cancérologie Thoracique, Paris, France.<br /><searchLink fieldCode="AU" term="%22Zalcman+G%22">Zalcman G</searchLink>; Université Paris Cité, Thoracic Oncology Department, Centre d'Investigation Clinique Institut National de la Santé et de la Recherche Médicale 1425, Hôpital Bichat-Claude Bernard, Institut du Cancer - Assistance Publique-Hôpitaux de Paris Nord, Paris, France.<br /><searchLink fieldCode="AU" term="%22Giraud+P%22">Giraud P</searchLink>; Oncology Radiotherapy Department, Paris Cité University, European Hospital Georges-Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100957246%22">The Lancet. Oncology</searchLink> [Lancet Oncol] 2024 Sep; Vol. 25 (9), pp. 1176-1187. <i>Date of Electronic Publication: </i>2024 Aug 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Clinical Trial, Phase II; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lancet+Pub%2E+Group%22">Lancet Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100957246 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-5488 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214702045%22">14702045 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39134086 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1470-2045(24)00320-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1176 Titles: – TitleFull: Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Vera P – PersonEntity: Name: NameFull: Thureau S – PersonEntity: Name: NameFull: Le Tinier F – PersonEntity: Name: NameFull: Chaumet-Riffaud P – PersonEntity: Name: NameFull: Hapdey S – PersonEntity: Name: NameFull: Kolesnikov-Gauthier H – PersonEntity: Name: NameFull: Martin E – PersonEntity: Name: NameFull: Berriolo-Riedinger A – PersonEntity: Name: NameFull: Pourel N – PersonEntity: Name: NameFull: Broglia JM – PersonEntity: Name: NameFull: Boissellier P – PersonEntity: Name: NameFull: Guillemard S – PersonEntity: Name: NameFull: Salem N – PersonEntity: Name: NameFull: Brenot-Rossi I – PersonEntity: Name: NameFull: Le Péchoux C – PersonEntity: Name: NameFull: Berthold C – PersonEntity: Name: NameFull: Giroux-Leprieur E – PersonEntity: Name: NameFull: Moreau D – PersonEntity: Name: NameFull: Guillerm S – PersonEntity: Name: NameFull: Benali K – PersonEntity: Name: NameFull: Tessonnier L – PersonEntity: Name: NameFull: Audigier-Valette C – PersonEntity: Name: NameFull: Lerouge D – PersonEntity: Name: NameFull: Quak E – PersonEntity: Name: NameFull: Massabeau C – PersonEntity: Name: NameFull: Courbon F – PersonEntity: Name: NameFull: Moisson P – PersonEntity: Name: NameFull: Larrouy A – PersonEntity: Name: NameFull: Modzelewski R – PersonEntity: Name: NameFull: Gouel P – PersonEntity: Name: NameFull: Ghazzar N – PersonEntity: Name: NameFull: Langlais A – PersonEntity: Name: NameFull: Amour E – PersonEntity: Name: NameFull: Zalcman G – PersonEntity: Name: NameFull: Giraud P IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2024 Sep Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1474-5488 Numbering: – Type: volume Value: 25 – Type: issue Value: 9 Titles: – TitleFull: The Lancet. Oncology Type: main |
| ResultId | 1 |
